Literature DB >> 12621461

Comparison between two strategies for umbilical cord blood collection.

P Solves1, R Moraga, E Saucedo, A Perales, M A Soler, L Larrea, V Mirabet, D Planelles, F Carbonell-Uberos, J Monleón, T Planells, M Guillén, A Andrés, E Franco.   

Abstract

The use of cord blood (CB) for transplantation has increased greatly in recent years. The collection strategy is the first step in collecting good-quality CB units. There are two main techniques for collecting CB from the umbilical vein: in the delivery room while the placenta is still in the uterus by midwives and obstetricians or in an adjacent room after placental delivery by CB bank trained personnel. In this study, the benefits and disadvantages between the two different CB collection strategies were evaluated, in order to improve CB bank methodology. Valencia CB bank maintains the two different collection strategies. CB was obtained from 569 vaginal and 70 caesarean deliveries and obstetrical and clinical charts were reviewed. Before processing CB units, volume was calculated and samples were drawn for cell counts. After processing and before cryopreservation samples were drawn for cell counts, CD34+cell analysis, viability, clonogenic assays and microbiology were drawn directly from the bags. We compared the efficiency of the two collection techniques. Obstetric data and umbilical CB were obtained from 569 vaginal (264 collected in utero and 305 collected ex utero) and 70 caesarean deliveries. The proportion of excluded CB units before processing was 33% for vaginal ex utero, 25% for vaginal in utero and 46% for caesarean deliveries. Differences were statistically significant. For vaginal deliveries a larger volume and a higher number of nucleated cells, percentage of CD34+ cells and colony-forming units (CFUs) were harvested in the in utero collection group. There was no statistical difference between CB collected after placental expulsion from vaginal and caesarean deliveries. Comparison between all vaginal and caesarean deliveries did not show any difference. We conclude that the mode of collection influences the haematopoietic content of CB donations. Collection before placental delivery is the best approach to CB collection and allows optimisation of CB bank methodology. Caesarean deliveries seem to contain similar progenitor content to vaginal deliveries.

Entities:  

Mesh:

Year:  2003        PMID: 12621461     DOI: 10.1038/sj.bmt.1703809

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  9 in total

1.  Induction of apoptosis in glioma cells requires cell-to-cell contact with human umbilical cord blood stem cells.

Authors:  Christopher S Gondi; Venkateswara R Gogineni; Chandramu Chetty; Venkata R Dasari; Bharathi Gorantla; Meena Gujrati; Dzung H Dinh; Jasti S Rao
Journal:  Int J Oncol       Date:  2010-05       Impact factor: 5.650

2.  Differential HIV-1 replication in neonatal and adult blood mononuclear cells is influenced at the level of HIV-1 gene expression.

Authors:  Vasudha Sundaravaradan; Shailendra K Saxena; Rajesh Ramakrishnan; Venkat R K Yedavalli; David T Harris; Nafees Ahmad
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-25       Impact factor: 11.205

3.  Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway.

Authors:  Venkata Ramesh Dasari; Kiranpreet Kaur; Kiran Kumar Velpula; Meena Gujrati; Daniel Fassett; Jeffrey D Klopfenstein; Dzung H Dinh; Jasti S Rao
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

4.  Cytotoxicity of human umbilical cord blood-derived mesenchymal stem cells against human malignant glioma cells.

Authors:  Seok-Gu Kang; Sin Soo Jeun; Jung Yeon Lim; Seong Muk Kim; Yoon Sun Yang; Won Il Oh; Pil-Woo Huh; Chun Kun Park
Journal:  Childs Nerv Syst       Date:  2007-10-30       Impact factor: 1.475

Review 5.  Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility.

Authors:  Olivier Hequet
Journal:  J Blood Med       Date:  2015-02-18

6.  Standardizing Umbilical Cord Mesenchymal Stromal Cells for Translation to Clinical Use: Selection of GMP-Compliant Medium and a Simplified Isolation Method.

Authors:  J Robert Smith; Kyle Pfeifer; Florian Petry; Natalie Powell; Jennifer Delzeit; Mark L Weiss
Journal:  Stem Cells Int       Date:  2016-02-04       Impact factor: 5.443

7.  Epigenome Wide Association and Stochastic Epigenetic Mutation Analysis on Cord Blood of Preterm Birth.

Authors:  Elena Spada; Luciano Calzari; Luigi Corsaro; Teresa Fazia; Monica Mencarelli; Anna Maria Di Blasio; Luisa Bernardinelli; Giulia Zangheri; Michele Vignali; Davide Gentilini
Journal:  Int J Mol Sci       Date:  2020-07-17       Impact factor: 5.923

8.  Multifactorial analysis of the stochastic epigenetic variability in cord blood confirmed an impact of common behavioral and environmental factors but not of in vitro conception.

Authors:  D Gentilini; E Somigliana; L Pagliardini; E Rabellotti; P Garagnani; L Bernardinelli; E Papaleo; M Candiani; A M Di Blasio; P Viganò
Journal:  Clin Epigenetics       Date:  2018-06-08       Impact factor: 6.551

Review 9.  Umbilical cord blood quality and quantity: Collection up to transplantation.

Authors:  Seyed Hadi Mousavi; Morteza Zarrabi; Saeid Abroun; Mona Ahmadipanah; Bahareh Abbaspanah
Journal:  Asian J Transfus Sci       Date:  2019-12-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.